Published in J Cardiol on May 31, 2013
The scientific achievements of the decades in Korean Acute Myocardial Infarction Registry. Korean J Intern Med (2014) 0.88
Percutaneous coronary intervention in the elderly with ST-segment elevation myocardial infarction. Clin Interv Aging (2014) 0.83
Clinical characteristics and outcomes of octogenarians presenting with ST elevation myocardial infarction in the Australian population. World J Cardiol (2017) 0.75
Duration of dual antiplatelet therapy after implantation of drug-eluting stents. N Engl J Med (2010) 6.37
Trial of everolimus-eluting stents or bypass surgery for coronary disease. N Engl J Med (2015) 4.27
Randomized trial of stents versus bypass surgery for left main coronary artery disease. N Engl J Med (2011) 3.55
Prediction of progression of coronary artery disease and clinical outcomes using vascular profiling of endothelial shear stress and arterial plaque characteristics: the PREDICTION Study. Circulation (2012) 3.53
Evaluation of effectiveness of prophylactic cerclage of a short cervix according to interleukin-8 in cervical mucus. Am J Obstet Gynecol (2006) 3.01
Nuclear targeting of Akt enhances kinase activity and survival of cardiomyocytes. Circ Res (2004) 2.91
Silica and titanium dioxide nanoparticles cause pregnancy complications in mice. Nat Nanotechnol (2011) 2.79
Percutaneous coronary intervention for nonculprit vessels in cardiogenic shock complicating ST-segment elevation acute myocardial infarction. Crit Care Med (2014) 2.70
Improvement of arterial stiffness in the transition from acute decompensated heart failure to chronic compensated heart failure. Clin Cardiol (2013) 2.67
Triple versus dual antiplatelet therapy in patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Circulation (2009) 2.62
Inhibition of histone deacetylation blocks cardiac hypertrophy induced by angiotensin II infusion and aortic banding. Circulation (2005) 2.44
Echocardiographic epicardial fat thickness and coronary artery disease. Circ J (2007) 2.40
Clinical benefit of statin pretreatment in patients undergoing percutaneous coronary intervention: a collaborative patient-level meta-analysis of 13 randomized studies. Circulation (2011) 2.34
The clopidogrel resistance can be attenuated with triple antiplatelet therapy in patients undergoing drug-eluting stents implantation. Int J Cardiol (2008) 2.31
A new strategy for discontinuation of dual antiplatelet therapy: the RESET Trial (REal Safety and Efficacy of 3-month dual antiplatelet Therapy following Endeavor zotarolimus-eluting stent implantation). J Am Coll Cardiol (2012) 2.28
Potential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver. Development (2009) 2.26
High prevalence of occult coronary artery stenosis in patients with chronic kidney disease at the initiation of renal replacement therapy: an angiographic examination. J Am Soc Nephrol (2005) 2.25
A multicenter randomized comparison of paclitaxel-coated balloon catheter with conventional balloon angioplasty in patients with bare-metal stent restenosis and drug-eluting stent restenosis. Am Heart J (2013) 2.19
Plaque prolapse after stent implantation in patients with acute myocardial infarction: an intravascular ultrasound analysis. JACC Cardiovasc Imaging (2008) 2.13
Transradial cardiac catheterization: a review of access site complications. Catheter Cardiovasc Interv (2011) 2.13
Sex differences in central hemodynamics and their relationship to left ventricular diastolic function. J Am Coll Cardiol (2011) 2.13
Low-molecular-weight heparin versus unfractionated heparin in acute ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with drug-eluting stents. Am Heart J (2010) 2.09
A paclitaxel-eluting stent for the prevention of coronary restenosis. N Engl J Med (2003) 2.07
Transradial coronary intervention using a novel 5-Fr sheathless guiding catheter. Catheter Cardiovasc Interv (2009) 2.07
Incremental predictive value of red cell distribution width for 12-month clinical outcome after acute myocardial infarction. Clin Cardiol (2013) 2.05
Testosterone is responsible for enhanced susceptibility of males to ischemic renal injury. J Biol Chem (2004) 1.96
A20 is dynamically regulated in the heart and inhibits the hypertrophic response. Circulation (2003) 1.94
Benefit of early statin therapy in patients with acute myocardial infarction who have extremely low low-density lipoprotein cholesterol. J Am Coll Cardiol (2011) 1.79
Safety and effect of adipose tissue-derived stem cell implantation in patients with critical limb ischemia: a pilot study. Circ J (2012) 1.79
Prospective study of serum adiponectin and incident metabolic syndrome: the ARIRANG study. Diabetes Care (2012) 1.71
Use of rocuronium-sugammadex, an alternative to succinylcholine, as a muscle relaxant during electroconvulsive therapy. J Anesth (2011) 1.67
Effectiveness and safety of endovascular aneurysm treatment in patients with vasculo-Behçet disease. J Endovasc Ther (2009) 1.66
Efficacy of high-dose atorvastatin loading before primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: the STATIN STEMI trial. JACC Cardiovasc Interv (2010) 1.65
Incidences, predictors, and clinical outcomes of acute and late stent malapposition detected by optical coherence tomography after drug-eluting stent implantation. Circ Cardiovasc Interv (2014) 1.62
Procedural outcomes of repeated transradial coronary procedure. Catheter Cardiovasc Interv (2003) 1.62
Influence of weather on daily hospital admissions for acute myocardial infarction (from the Korea Acute Myocardial Infarction Registry). Int J Cardiol (2009) 1.62